Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06953674 · ClinicalTrials.gov registry record · Phase 3
Saline Versus Balanced Crystalloid in Traumatic Brain Injury
A Phase 3 study of Traumatic Brain Injury (TBI) Patients, sponsored by University of Louisville.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06953674 is a Phase 3 study of Traumatic Brain Injury (TBI) Patients that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 600 participants, above the 46-participant average among 4 other Traumatic Brain Injury (TBI) Patients trials with a reported enrollment target (1204% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06953674, a Phase 3 study of Traumatic Brain Injury (TBI) Patients, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine which crystalloid (saline or balanced) should be used in the critical management of Traumatic Brain Injury (TBI) in moderate or severe TBI patients. This trial will determine whether the use of saline or balanced crystalloids is associated with improved outcomes in TBI patients. Participants will 1. be given fluids through the veins, either saline or balanced fluid will be given. 2. From the first day to the day 14 of the hospitalization (or discharge, whichever comes first), vital signs, laboratory values, treatments given, and other medical data will be collected from the medical record. 3. Six months later, your final disability, if any, will be assessed during your follow-up with a doctor. It involves answering a short survey that will take about 5 minutes or less.
Conditions Studied
Interventions
- DRUG Normal Saline (0.9% NaCl)
- DRUG balanced crystalloid
Study Locations (1)
Kentucky
- University of Louisville Hospital - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2029-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06953674
The ClinicalTrials.gov registry entry for NCT06953674 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 46-participant average among 4 other Traumatic Brain Injury (TBI) Patients trials with a reported enrollment target (1204% higher). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Brain Injury (TBI) Patients appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline (0.9% NaCl) is the first listed.
NCT06953674 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT06953674 about?
NCT06953674 is a clinical study titled "Saline Versus Balanced Crystalloid in Traumatic Brain Injury". The goal of this clinical trial is to determine which crystalloid (saline or balanced) should be used in the critical management of Traumatic Brain Injury (TBI) in moderate or severe TBI patients. This trial will determine whether the use of saline or balanced crystalloids is associated with improve...
What is the current status of trial NCT06953674?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2025-06-01. Estimated completion is 2029-09.
What conditions does trial NCT06953674 study?
This clinical trial studies the following conditions: Traumatic Brain Injury (TBI) Patients.
What interventions are being tested in trial NCT06953674?
The interventions under investigation include: Normal Saline (0.9% NaCl) (DRUG), balanced crystalloid (DRUG).
Who is sponsoring clinical trial NCT06953674?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06953674 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury (TBI) Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcutaneous Vagus Nerve Stimulation for Attention and Memory
RECRUITING · NA
-
Early Neuromodulation in Traumatic Brain Injury
RECRUITING · NA
-
Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury
RECRUITING · NA
-
External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.